Aspirin, a non-steroidal anti-inflammatory drug (NSAID), acts by irreversibly inhibiting cyclooxygenase (COX) enzymes, which reduces prostaglandin synthesis and modulates neuroinflammatory pathways. In the context of Visual Snow Syndrome, aspirin may potentially help mitigate neurological symptoms by reducing neural hyperexcitability and inflammatory processes, though its efficacy is not definitively established.